Sumayang, Mylen S.
HRN: 24-37-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2024
CEFUROXIME 1.5GM (VIAL)
01/06/2024
01/12/2024
IV
1.5
Once
For Stat Cs, Surgical Prophylaxis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes